Page last updated: 2024-12-07

glucogallin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

glucogallin: RN given refers to (D-glucose)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124375
MeSH IDM0167990

Synonyms (6)

Synonym
[(3r,4s,5s,6s)-3,4,5-trihydroxy-6-methoxyoxan-2-yl] 3,4,5-trihydroxybenzoate
58511-73-2
1-o-galloylglucose
d-glucose, 1-(3,4,5-trihydroxybenzoate)
glucogallin
DTXSID901029515

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" After the identification, six different brands of GFW commercial products in various dosage forms were evaluated."( Identification of multiple constituents in the traditional Chinese medicine formula GuiZhiFuLing-Wan by HPLC-DAD-MS/MS.
Chen, L; Wang, D; Wu, J; Yu, B; Zhu, D, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (48)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.08)18.7374
1990's3 (6.25)18.2507
2000's14 (29.17)29.6817
2010's18 (37.50)24.3611
2020's12 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (95.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]